pentetic acid has been researched along with Pituitary Neoplasms in 69 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Pituitary Neoplasms: Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to assess the role of MR imaging and the paramagnetic contrast agent Gadolinium-DTPA(Gd-DTPA) in the diagnosis of pituitary macroadenomas." | 7.67 | The value of paramagnetic contrast agent gadolinium-DTPA in the diagnosis of pituitary adenomas. ( Bittner, RC; Felix, R; Nakamura, T; Schörner, W, 1988) |
| "A dynamic study of magnetic resonance (MR) imaging was used to obtain successive heavily T1-weighted coronal images (spin-echo [SE] 100/15 [repetition time msec/echo time msec]) of normal pituitary glands and pituitary adenoma immediately after patients were given an intravenous bolus injection of gadopentetate dimeglumine." | 3.68 | Pituitary adenomas and normal pituitary tissue: enhancement patterns on gadopentetate-enhanced MR imaging. ( Kawamura, J; Keyaki, A; Kuroda, Y; Makita, Y; Matsuo, M; Miki, Y; Nishizawa, S, 1990) |
| "The purpose of this study was to assess the role of MR imaging and the paramagnetic contrast agent Gadolinium-DTPA(Gd-DTPA) in the diagnosis of pituitary macroadenomas." | 3.67 | The value of paramagnetic contrast agent gadolinium-DTPA in the diagnosis of pituitary adenomas. ( Bittner, RC; Felix, R; Nakamura, T; Schörner, W, 1988) |
| "To assess the role of magnetic resonance imaging in the evaluation of adrenocorticotropic-hormone (ACTH)-producing pituitary adenomas, and the effect of intravenously administered gadolinium-diethylenetriaminepentaacetic acid (DTPA) on lesion/pituitary contrast, imaging was performed in 13 patients with clinical and chemical evidence of Cushing disease." | 3.67 | Pituitary adenomas in patients with Cushing disease: initial experience with Gd-DTPA-enhanced MR imaging. ( Cutler, GB; Doppman, JL; Dwyer, AJ; Frank, JA; Hickey, AM; Loriaux, DL; Oldfield, EH; Schiable, TF, 1987) |
| "The adamantinous craniopharyngioma is a mixed solid-cystic or mainly cystic lobulated suprasellar or intrasellar/suprasellar tumor occurring in children and adults, typically with large nonenhancing hyperintense cysts on T1-weighted images." | 1.30 | MR differentiation of adamantinous and squamous-papillary craniopharyngiomas. ( Aguzzi, A; Sartoretti-Schefer, S; Valavanis, A; Wichmann, W, 1997) |
| "To present a new MR classification for pituitary adenomas, a grading system named SIPAP." | 1.30 | SIPAP--a new MR classification for pituitary adenomas. Suprasellar, infrasellar, parasellar, anterior and posterior. ( Edal, AL; Nepper-Rasmussen, HJ; Skjödt, K, 1997) |
| "Pituitary microprolactinomas are visible in a higher number of slices in 3D TSE sequences; the subjective scores for image quality and signal-to-noise ratios were similar in both 2D and 3D sequences; the contrast-to-noise ratio was always higher in 3D sequences." | 1.30 | Assessment of pituitary microadenomas: comparison between 2D and 3D MR sequences. ( Frezza, F; Longo, R; Magnaldi, S; Pozzi-Mucelli, RS; Razavi, IS; Ukmar, M, 1997) |
| "In patients with pituitary adenomas, the percent suppression of GH and alpha-subunit levels after 6-12 months of octreotide treatment (0." | 1.30 | The pituitary uptake of (111)In-DTPA-D-Phe1-octreotide in the normal pituitary and in pituitary adenomas. ( Acampa, W; Cerbone, G; Colao, A; Ferone, D; Lastoria, S; Lombardi, G; Marzullo, P; Pivonello, R; Salvatore, M; Varrella, P, 1999) |
| "In contrast to previous reports, pituitary adenomas were found to enhance earlier than the anterior lobe." | 1.29 | Sequential MR enhancement pattern in normal pituitary gland and in pituitary adenoma. ( Fisher, DJ; Gao, F; Nguyen, HD; Schlechte, JA; Simonson, TM; Tali, ET; Yuh, WT, 1994) |
| "Occult pituitary adenomas are identified at autopsy in 3% to 27% of unselected asymptomatic patients." | 1.29 | Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. ( Doppman, JL; Hall, WA; Luciano, MG; Oldfield, EH; Patronas, NJ, 1994) |
| "In 10 patients, cysts showed isointensity to high intensity on T1-weighted images and had various intensity on T2-weighted images." | 1.29 | Rathke cleft cysts: correlation of enhanced MR and surgical findings. ( Arita, K; Eguchi, K; Kurisu, K; Mukada, K; Sumida, M; Uozumi, T, 1994) |
| "Two patients presented with multiple meningiomas, of which one showed two histologically different tumor types." | 1.29 | The association of meningioma and pituitary adenoma: report of seven cases and review of the literature. ( Abs, R; Mahler, C; Martin, JJ; Parizel, PM; Van de Kelft, E; Van Marck, E; Verhelst, J; Verlooy, J; Willems, PJ, 1993) |
| "Pituitary tumors were slightly positive in 50% of cases only, independent of the endocrine activity." | 1.29 | Somatostatin receptor scintigraphy in brain tumors and pituitary tumors: first experiences. ( Hildebrandt, G; Klug, N; Luyken, C; Scheidhauer, K; Schicha, H; Schomäcker, K, 1993) |
| "Although in cases of residual tumor follow-up MR imaging was performed over a period of two years, residual tumor volumes did not appear to change." | 1.29 | MR imaging of residual tumor tissue after transsphenoidal surgery of hormone-inactive pituitary macroadenomas: a prospective study. ( Forsting, M; Hamer, J; Kremer, P; Sartor, K, 1996) |
| " Lower variability was observed in the fixed ROI method in which activity was expressed as counts corrected for dosage and body weight." | 1.29 | Indium-111-DTPA-octreotide uptake measured in normal and abnormal pituitary glands. ( Meylaerts, SA; Miedema, AR; van Royen, EA; Verhoeff, NP, 1996) |
| "In 25 pituitary adenomas with surgically proven infiltration into the space of the cavernous sinus we correlated the MRI findings with our surgical observations." | 1.28 | Pituitary adenomas with parasellar invasion. ( Kitz, K; Knosp, E; Matula, C; Steiner, E, 1991) |
| "The peak enhancement of pituitary adenomas occurred at 60-200 seconds, usually after the most marked enhancement of the normal pituitary gland." | 1.28 | Normal and abnormal pituitary glands: gadopentetate dimeglumine-enhanced MR imaging. ( Bussaka, H; Korogi, Y; Sakamoto, Y; Takahashi, M; Ushio, Y, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (18.84) | 18.7374 |
| 1990's | 52 (75.36) | 18.2507 |
| 2000's | 4 (5.80) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acosta-Gómez, MJ | 1 |
| Muros, MA | 1 |
| Llamas-Elvira, JM | 1 |
| Ramírez, A | 1 |
| Ortega, S | 1 |
| Sabatel, G | 1 |
| Ramos, C | 1 |
| de la Riva-Aguilar, A | 1 |
| Schörner, W | 2 |
| Kazner, E | 1 |
| Laniado, M | 2 |
| Sprung, C | 1 |
| Felix, R | 3 |
| Chanson, P | 1 |
| Schaison, G | 1 |
| Koshimoto, Y | 1 |
| Maeda, M | 1 |
| Naiki, H | 1 |
| Nakakuki, K | 1 |
| Ishii, Y | 1 |
| Wu, W | 1 |
| Thuomas, KA | 1 |
| Lindsey, RO | 1 |
| Yetkin, FZ | 1 |
| Prost, R | 1 |
| Haughton, VM | 4 |
| Ahmadi, J | 2 |
| Meyers, GS | 1 |
| Segall, HD | 2 |
| Sharma, OP | 1 |
| Hinton, DR | 1 |
| Hald, JK | 2 |
| Eldevik, OP | 1 |
| Brunberg, JA | 1 |
| Chandler, WF | 1 |
| Steiner, E | 4 |
| Math, G | 1 |
| Knosp, E | 4 |
| Mostbeck, G | 1 |
| Kramer, J | 1 |
| Herold, CJ | 1 |
| Colombo, N | 1 |
| Loli, P | 1 |
| Vignati, F | 1 |
| Scialfa, G | 1 |
| Sumida, M | 2 |
| Uozumi, T | 2 |
| Mukada, K | 2 |
| Arita, K | 2 |
| Kurisu, K | 2 |
| Yano, T | 1 |
| Onda, J | 1 |
| Satoh, H | 1 |
| Ikawa, F | 1 |
| Kobayashi, S | 1 |
| Ikeda, H | 1 |
| Yoshimoto, T | 1 |
| Kucharczyk, W | 1 |
| Bishop, JE | 1 |
| Plewes, DB | 1 |
| Keller, MA | 1 |
| George, S | 1 |
| Yuh, WT | 2 |
| Fisher, DJ | 2 |
| Nguyen, HD | 2 |
| Tali, ET | 2 |
| Gao, F | 1 |
| Simonson, TM | 1 |
| Schlechte, JA | 1 |
| Hall, WA | 1 |
| Luciano, MG | 1 |
| Doppman, JL | 2 |
| Patronas, NJ | 1 |
| Oldfield, EH | 2 |
| Lafitte, C | 1 |
| Aesch, B | 1 |
| Henry-Lebras, F | 1 |
| Fetissof, F | 1 |
| Jan, M | 1 |
| Eguchi, K | 1 |
| Tsunoda, S | 1 |
| Sakaki, T | 1 |
| Tsutsumi, A | 1 |
| Eguchi, T | 1 |
| Takeshima, T | 1 |
| Morimoto, T | 1 |
| Hashimoto, H | 1 |
| Kiriishi, R | 1 |
| Nakamura, M | 1 |
| Tsuzuki, T | 1 |
| Skalpe, IO | 1 |
| Bakke, SJ | 1 |
| Nakstad, PH | 1 |
| Abs, R | 1 |
| Parizel, PM | 1 |
| Willems, PJ | 1 |
| Van de Kelft, E | 1 |
| Verlooy, J | 1 |
| Mahler, C | 1 |
| Verhelst, J | 1 |
| Van Marck, E | 1 |
| Martin, JJ | 1 |
| Scheidhauer, K | 1 |
| Hildebrandt, G | 1 |
| Luyken, C | 1 |
| Schomäcker, K | 1 |
| Klug, N | 1 |
| Schicha, H | 1 |
| Finelli, DA | 1 |
| Kaufman, B | 1 |
| Schild, H | 1 |
| Strack, T | 1 |
| Strunk, H | 1 |
| Mildenberger, P | 1 |
| Schrezenmeir, J | 1 |
| Kahaly, G | 1 |
| Beyer, J | 1 |
| Kaiser, WA | 1 |
| Steckelbroeck, V | 1 |
| Siewert, B | 1 |
| Layer, G | 1 |
| Hochstetter, A | 1 |
| Reiser, M | 1 |
| Anderson, CJ | 1 |
| Pajeau, TS | 1 |
| Edwards, WB | 1 |
| Sherman, EL | 1 |
| Rogers, BE | 1 |
| Welch, MJ | 1 |
| Kurki, T | 1 |
| Lundbom, N | 1 |
| Valtonen, S | 1 |
| Kremer, P | 1 |
| Forsting, M | 1 |
| Hamer, J | 1 |
| Sartor, K | 1 |
| van Royen, EA | 1 |
| Verhoeff, NP | 1 |
| Meylaerts, SA | 1 |
| Miedema, AR | 1 |
| Niwa, J | 1 |
| Tanabe, S | 1 |
| Ibayashi, Y | 1 |
| Hashi, K | 1 |
| Boni, G | 1 |
| Ferdeghini, M | 1 |
| Bellina, CR | 1 |
| Matteucci, F | 1 |
| Castro Lopez, E | 1 |
| Parenti, G | 1 |
| Canapicchi, R | 1 |
| Bianchi, R | 1 |
| Tofani, A | 1 |
| Cucchi, R | 1 |
| Pompili, A | 1 |
| Carapella, C | 1 |
| Crecco, M | 1 |
| Mottolese, M | 1 |
| Maini, CL | 1 |
| Sartoretti-Schefer, S | 1 |
| Wichmann, W | 1 |
| Aguzzi, A | 1 |
| Valavanis, A | 1 |
| Edal, AL | 1 |
| Skjödt, K | 1 |
| Nepper-Rasmussen, HJ | 1 |
| Magnaldi, S | 1 |
| Frezza, F | 1 |
| Longo, R | 1 |
| Ukmar, M | 1 |
| Razavi, IS | 1 |
| Pozzi-Mucelli, RS | 1 |
| Lundin, P | 2 |
| Edén Engström, B | 1 |
| Karlsson, FA | 1 |
| Burman, P | 1 |
| Marro, B | 1 |
| Zouaoui, A | 1 |
| Sahel, M | 1 |
| Crozat, N | 1 |
| Gerber, S | 1 |
| Sourour, N | 1 |
| Sag, K | 1 |
| Marsault, C | 1 |
| Celli, P | 1 |
| Cervoni, L | 1 |
| Cantore, G | 1 |
| Chattopadhyay, S | 2 |
| Freake, HC | 2 |
| Rao, VM | 1 |
| Vinitski, S | 1 |
| Babaria, A | 1 |
| Flanders, A | 1 |
| Mishkin, MM | 1 |
| Gonzalez, C | 1 |
| Colao, A | 3 |
| Lastoria, S | 3 |
| Ferone, D | 1 |
| Varrella, P | 1 |
| Marzullo, P | 1 |
| Pivonello, R | 1 |
| Cerbone, G | 1 |
| Acampa, W | 1 |
| Salvatore, M | 1 |
| Lombardi, G | 3 |
| Breeman, WA | 1 |
| Hofland, LJ | 1 |
| de Jong, M | 1 |
| Bernard, BF | 1 |
| Srinivasan, A | 1 |
| Kwekkeboom, DJ | 2 |
| Visser, TJ | 1 |
| Krenning, EP | 2 |
| Sciaudone, MP | 1 |
| Berger, F | 1 |
| Meyer, G | 1 |
| Weiss, M | 1 |
| Pfluger, T | 1 |
| Horn, K | 1 |
| Tatsch, K | 1 |
| Hahn, K | 1 |
| Dorato, M | 1 |
| Pulcrano, M | 1 |
| Rossi, FW | 1 |
| Auriemma, RS | 1 |
| Reubi, JC | 1 |
| Van Hagen, PM | 1 |
| van Eijck, CH | 1 |
| Oei, HY | 1 |
| Lamberts, SW | 1 |
| Taylor, SL | 1 |
| Barakos, JA | 1 |
| Harsh, GR | 1 |
| Wilson, CB | 1 |
| Mayr, NA | 1 |
| Destian, S | 1 |
| Apuzzo, ML | 1 |
| Zee, CS | 1 |
| Bergström, K | 1 |
| Kitz, K | 1 |
| Matula, C | 1 |
| Davis, PC | 1 |
| Gokhale, KA | 1 |
| Joseph, GJ | 1 |
| Peterman, SB | 1 |
| Adams, DA | 1 |
| Tindall, GT | 1 |
| Hudgins, PA | 1 |
| Hoffman, JC | 1 |
| Sakamoto, Y | 1 |
| Takahashi, M | 1 |
| Korogi, Y | 1 |
| Bussaka, H | 1 |
| Ushio, Y | 1 |
| Shen, TZ | 1 |
| Mei, H | 1 |
| Huang, XL | 1 |
| Chen, XR | 1 |
| van Nesselrooij, JH | 1 |
| Szeverenyi, NM | 1 |
| Tillapaugh-Fay, GM | 1 |
| Hendriksen, FG | 1 |
| Bronen, RA | 1 |
| Sze, G | 1 |
| Miki, Y | 1 |
| Matsuo, M | 1 |
| Nishizawa, S | 1 |
| Kuroda, Y | 1 |
| Keyaki, A | 1 |
| Makita, Y | 1 |
| Kawamura, J | 1 |
| Wimberger, D | 1 |
| Imhof, H | 2 |
| Hajek, P | 1 |
| Macpherson, P | 1 |
| Hadley, DM | 1 |
| Teasdale, E | 1 |
| Teasdale, G | 1 |
| Simon, JH | 1 |
| Szumowski, J | 1 |
| Runge, VM | 1 |
| Schoerner, W | 1 |
| Niendorf, HP | 1 |
| Koehler, D | 1 |
| Claussen, C | 1 |
| James, AE | 1 |
| Breger, RK | 2 |
| Papke, RA | 2 |
| Pojunas, KW | 1 |
| Williams, AL | 3 |
| Daniels, DL | 2 |
| Bartolozzi, C | 1 |
| Olmastroni, M | 1 |
| Dal Pozzo, G | 1 |
| Petacchi, D | 1 |
| Nakamura, T | 1 |
| Bittner, RC | 1 |
| Czervionke, LF | 2 |
| Bonneville, JF | 1 |
| Cattin, F | 1 |
| Mark, LP | 1 |
| Pech, P | 1 |
| Hendrix, LE | 2 |
| Smith, DF | 1 |
| Rimm, AA | 1 |
| Fisher, ME | 1 |
| Strother, CM | 1 |
| Turski, PA | 1 |
| Dwyer, AJ | 1 |
| Frank, JA | 1 |
| Hickey, AM | 1 |
| Cutler, GB | 1 |
| Loriaux, DL | 1 |
| Schiable, TF | 1 |
| Goldstein, EJ | 1 |
| Burnett, KR | 1 |
| Wolf, GL | 1 |
| Wortman, J | 1 |
| Joseph, P | 1 |
| Sen, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of the Posterior Septectomy and Stamm Approach to Endoscopic Pituitary Adenoma Resection: A Randomized, Single-blind Trial[NCT01689064] | 55 participants (Anticipated) | Interventional | 2012-09-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for pentetic acid and Pituitary Neoplasms
| Article | Year |
|---|---|
[Somatostatin analogs in the clinical management of pituitary neoplasms].
Topics: Acromegaly; Adenoma; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Agents, Hormon | 2001 |
111In-octreotide scintigraphy in oncology.
Topics: Acromegaly; Adenoma; Humans; Indium Radioisotopes; Multiple Endocrine Neoplasia; Octreotide; Penteti | 1992 |
The application of contrast agents in the evaluation of neoplasms of the central nervous system.
Topics: Brain Neoplasms; Cerebellar Neoplasms; Cerebellopontine Angle; Contrast Media; Gadolinium; Gadoliniu | 1992 |
Magnetic resonance imaging contrast agents: theory and application to the central nervous system.
Topics: Animals; Brain Diseases; Brain Neoplasms; Contrast Media; Gadolinium DTPA; Humans; Magnetic Resonanc | 1990 |
5 trials available for pentetic acid and Pituitary Neoplasms
| Article | Year |
|---|---|
Effect of dose and field strength on enhancement with paramagnetic contrast media.
Topics: Brain Neoplasms; Cavernous Sinus; Choroid Plexus; Contrast Media; Drug Combinations; Gadolinium DTPA | 1994 |
Detection of pituitary microadenomas: comparison of dynamic keyhole fast spin-echo, unenhanced, and conventional contrast-enhanced MR imaging.
Topics: Adenoma; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Re | 1994 |
MR imaging of pituitary region lesions with gadodiamide injection.
Topics: Adenoma; Adult; Aged; Contrast Media; Craniopharyngioma; Drug Combinations; Female; Gadolinium; Gado | 1994 |
Pituitary microadenomas. Does Gadolinium enhance their demonstration?
Topics: Adenoma; Adult; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Female; Gadolinium DTP | 1989 |
Benign extraaxial tumors: contrast enhancement with Gd-DTPA.
Topics: Adenoma; Clinical Trials as Topic; Contrast Media; Gadolinium; Gadolinium DTPA; Head and Neck Neopla | 1987 |
60 other studies available for pentetic acid and Pituitary Neoplasms
| Article | Year |
|---|---|
The role of somatostatin receptor scintigraphy in patients with pituitary adenoma or post-surgical recurrent tumours.
Topics: Adenoma; Adolescent; Adult; Aged; Child; Female; Follow-Up Studies; Humans; Magnetic Resonance Imagi | 2005 |
Magnetic resonance tomography (MRT) of intracranial tumours: initial experience with the use of the contrast medium Gadolinium-DTPA.
Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Carcinoma, Bronchogenic; Cerebellar Neoplasms; Craniophar | 1984 |
Pituitary apoplexy caused by GnRH-agonist treatment revealing gonadotroph adenoma.
Topics: Adenoma; Aged; Contrast Media; Cyproterone Acetate; Gadolinium; Gadolinium DTPA; Humans; Magnetic Re | 1995 |
MR of pituitary metastasis in a patient with diabetes insipidus.
Topics: Aged; Carcinoma, Small Cell; Contrast Media; Diabetes Insipidus; Drug Combinations; Fatal Outcome; G | 1995 |
Pituitary microadenoma. MR appearance and correlation with CT.
Topics: Adenoma; Adult; Aged; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonanc | 1995 |
Lymphocytic adenohypophysitis: contrast-enhanced MR imaging in five cases.
Topics: Adenoma; Adolescent; Adult; Autoimmune Diseases; Contrast Media; Diagnosis, Differential; Drug Combi | 1995 |
Craniopharyngiomas--the utility of contrast medium enhancement for MR imaging at 1.5 T.
Topics: Adolescent; Adult; Child; Child, Preschool; Contrast Media; Craniopharyngioma; Drug Combinations; Fe | 1994 |
MR-appearance of the pituitary gland before and after resection of pituitary macroadenomas.
Topics: Adenoma; Adult; Aged; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic R | 1994 |
MR of corticotropin-secreting pituitary microadenomas.
Topics: Adenoma; Adolescent; Adrenocorticotropic Hormone; Adult; Contrast Media; Cushing Syndrome; Drug Comb | 1994 |
MRI of pituitary adenomas: the position of the normal pituitary gland.
Topics: Adenoma; Adrenocorticotropic Hormone; Contrast Media; Diagnosis, Differential; Gadolinium DTPA; Grow | 1994 |
A clinical and histopathological study of factors affecting MRI signal intensities of pituitary adenomas.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Aged; Cell Count; Contrast Media; Drug Combinations; Fe | 1994 |
Sequential MR enhancement pattern in normal pituitary gland and in pituitary adenoma.
Topics: Adenoma; Contrast Media; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Org | 1994 |
Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population.
Topics: Adenoma; Adolescent; Adult; Contrast Media; Cushing Syndrome; Female; Gadolinium; Gadolinium DTPA; H | 1994 |
Granular cell tumor of the pituitary stalk. Case report.
Topics: Adult; Contrast Media; Female; Gadolinium DTPA; Granular Cell Tumor; Humans; Immunohistochemistry; M | 1994 |
Rathke cleft cysts: correlation of enhanced MR and surgical findings.
Topics: Adenoma; Adolescent; Adult; Aged; Contrast Media; Craniopharyngioma; Cysts; Diagnosis, Differential; | 1994 |
Clinicopathological study on craniopharyngioma with sebaceous differentiation.
Topics: Child; Contrast Media; Craniopharyngioma; Gadolinium DTPA; Humans; Immunohistochemistry; Magnetic Re | 1993 |
The association of meningioma and pituitary adenoma: report of seven cases and review of the literature.
Topics: Adenoma; Adrenocorticotropic Hormone; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium DT | 1993 |
Somatostatin receptor scintigraphy in brain tumors and pituitary tumors: first experiences.
Topics: Adult; Aged; Biomarkers, Tumor; Brain Neoplasms; Female; Growth Hormone; Humans; Indium Radioisotope | 1993 |
Varied microcirculation of pituitary adenomas at rapid, dynamic, contrast-enhanced MR imaging.
Topics: Adenoma; Adult; Aged; Carotid Arteries; Cavernous Sinus; Contrast Media; Drug Combinations; Gadolini | 1993 |
[Selective blood sampling from the sinus petrosus inferior: a comparison of CRF and TRH stimulation].
Topics: Adenoma; Adrenocorticotropic Hormone; Contrast Media; Corticotropin-Releasing Hormone; Cranial Sinus | 1993 |
[Differentiating between tumor and implant material in the postoperative sella using MRT].
Topics: Adenoma; Adult; Aged; Contrast Media; Female; Follow-Up Studies; Foreign Bodies; Gadolinium; Gadolin | 1993 |
In vitro and in vivo evaluation of copper-64-octreotide conjugates.
Topics: Adrenal Glands; Animals; Copper Radioisotopes; Female; Indium Radioisotopes; Male; Mice; Octreotide; | 1995 |
Tissue characterisation of intracranial tumours: the value of magnetisation transfer and conventional MRI.
Topics: Adenoma; Brain; Brain Neoplasms; Contrast Media; Diagnosis, Differential; Gadolinium DTPA; Hemangiob | 1995 |
MR imaging of residual tumor tissue after transsphenoidal surgery of hormone-inactive pituitary macroadenomas: a prospective study.
Topics: Adenoma; Adult; Aged; Contrast Media; Craniotomy; Female; Follow-Up Studies; Gadolinium DTPA; Humans | 1996 |
Indium-111-DTPA-octreotide uptake measured in normal and abnormal pituitary glands.
Topics: Adenoma; Adult; Aged; Case-Control Studies; Female; Humans; Indium Radioisotopes; Male; Middle Aged; | 1996 |
[Clinicopathological findings in symptomatic Rathke's cleft cyst: correlation between enhancement effects on MRI and histopathology of the cyst wall].
Topics: Adult; Contrast Media; Craniopharyngioma; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Reso | 1996 |
[111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Female; Human Growth Hormo | 1995 |
111In-octreotide scintigraphy in pituitary adenomas.
Topics: Adenoma; Antineoplastic Agents, Hormonal; Human Growth Hormone; Humans; Immunohistochemistry; Indium | 1995 |
MR differentiation of adamantinous and squamous-papillary craniopharyngiomas.
Topics: Adolescent; Adult; Calcinosis; Child; Child, Preschool; Contrast Media; Craniopharyngioma; Diagnosis | 1997 |
SIPAP--a new MR classification for pituitary adenomas. Suprasellar, infrasellar, parasellar, anterior and posterior.
Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium; Gadolinium | 1997 |
Assessment of pituitary microadenomas: comparison between 2D and 3D MR sequences.
Topics: Adult; Aged; Artifacts; Contrast Media; Evaluation Studies as Topic; Female; Follow-Up Studies; Gado | 1997 |
Long-term octreotide therapy in growth hormone-secreting pituitary adenomas: evaluation with serial MR.
Topics: Acromegaly; Adenoma; Adult; Aged; Antineoplastic Agents, Hormonal; Contrast Media; Drug Combinations | 1997 |
MRI of pituitary adenomas in acromegaly.
Topics: Acromegaly; Adenoma; Adolescent; Adult; Aged; Child; Contrast Media; Female; Follicle Stimulating Ho | 1997 |
Dural tail in pituitary adenoma.
Topics: Adenoma; Choristoma; Contrast Media; Diagnosis, Differential; Dura Mater; Female; Gadolinium; Gadoli | 1997 |
Zinc chelation enhances thyroid hormone induction of growth hormone mRNA in GH3 cells.
Topics: Animals; Chelating Agents; Dexamethasone; Gene Expression; Growth Hormone; Pentetic Acid; Pituitary | 1998 |
Enhanced resolution of pituitary fossa by three-dimensional fat-suppressed gradient-echo magnetic resonance: before and after gadolinium enhancement.
Topics: Adenoma; Contrast Media; Empty Sella Syndrome; Gadolinium; Humans; Lipids; Magnetic Resonance Imagin | 1991 |
The pituitary uptake of (111)In-DTPA-D-Phe1-octreotide in the normal pituitary and in pituitary adenomas.
Topics: Adenoma; Adolescent; Adult; Aged; Female; Humans; Indium Radioisotopes; Male; Middle Aged; Octreotid | 1999 |
Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy.
Topics: Amino Acid Sequence; Animals; Bombesin; Female; Indium Radioisotopes; Pentetic Acid; Pituitary Neopl | 1999 |
Receptor imaging in the diagnosis and treatment of pituitary tumors.
Topics: Antineoplastic Agents, Hormonal; Humans; Indium Radioisotopes; Octreotide; Pentetic Acid; Pituitary | 1999 |
Chelation of zinc amplifies induction of growth hormone mRNA levels in cultured rat pituitary tumor cells.
Topics: Analysis of Variance; Animals; Antineoplastic Agents; Blotting, Northern; Chelating Agents; Drug Int | 2000 |
[Diagnostic imaging of a TSH-producing pituitary adenoma associated with the "empty sella" by somatostatin and dopamine D2 receptor scintigraphy].
Topics: Adenoma; Aged; Empty Sella Syndrome; Female; Humans; Indium Radioisotopes; Magnetic Resonance Imagin | 2000 |
Magnetic resonance imaging of tuberculum sellae meningiomas: preventing preoperative misdiagnosis as pituitary macroadenoma.
Topics: Adenoma; Adult; Aged; Contrast Media; Diagnosis, Differential; Female; Gadolinium DTPA; Humans; Magn | 1992 |
Cystic fluid in craniopharyngiomas: MR imaging and quantitative analysis.
Topics: Adolescent; Adult; Cholesterol; Contrast Media; Craniopharyngioma; Drug Combinations; Exudates and T | 1992 |
Gd-DTPA-enhanced MR imaging of pituitary macroadenomas.
Topics: Adenoma; Adult; Aged; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement | 1992 |
Pituitary adenomas with parasellar invasion.
Topics: Adenoma; Adult; Aged; Biomarkers, Tumor; Cavernous Sinus; Cell Division; Contrast Media; Female; Gad | 1991 |
Pituitary adenoma: correlation of half-dose gadolinium-enhanced MR imaging with surgical findings in 26 patients.
Topics: Adenoma; Adolescent; Adult; Aged; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonanc | 1991 |
Normal and abnormal pituitary glands: gadopentetate dimeglumine-enhanced MR imaging.
Topics: Adenoma; Contrast Media; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Organometallic Compoun | 1991 |
Application of Gd-DTPA in diseases of the central nervous system.
Topics: Adenoma; Adolescent; Adult; Aged; Brain Neoplasms; Female; Gadolinium DTPA; Glioma; Humans; Magnetic | 1991 |
Gadolinium-DTPA-enhanced and digitally subtracted magnetic resonance imaging of estrogen-induced pituitary lesions in rats: correlation with pituitary anatomy.
Topics: Animals; Brain; Contrast Media; Cysts; Estradiol; Gadolinium; Gadolinium DTPA; Hemorrhage; Hypertrop | 1990 |
Pituitary adenomas and normal pituitary tissue: enhancement patterns on gadopentetate-enhanced MR imaging.
Topics: Adenoma; Adult; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonan | 1990 |
[Gd-DTPA in the MR diagnosis of pituitary adenomas].
Topics: Adenoma; Adult; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imag | 1989 |
Chemical shift imaging with paramagnetic contrast material enhancement for improved lesion depiction.
Topics: Contrast Media; Cranial Nerve Neoplasms; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Ima | 1989 |
Gd-DTPA enhanced high resolution MR imaging of pituitary adenomas.
Topics: Adenoma; Adult; Aged; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonanc | 1989 |
Initial clinical evaluation of gadolinium DTPA for contrast-enhanced magnetic resonance imaging.
Topics: Brain Edema; Brain Neoplasms; Contrast Media; Diagnosis, Differential; Glioblastoma; Humans; Magneti | 1985 |
[Gadolinium DTPA in a MR study of expansive lesions of the cranial base].
Topics: Adenoma; Adult; Brain Neoplasms; Cranial Fossa, Posterior; Evaluation Studies as Topic; Female; Gado | 1988 |
The value of paramagnetic contrast agent gadolinium-DTPA in the diagnosis of pituitary adenomas.
Topics: Adenoma; Contrast Media; Gadolinium; Gadolinium DTPA; Growth Hormone; Humans; Magnetic Resonance Ima | 1988 |
MR imaging of the cavernous sinus: value of spin echo and gradient recalled echo images.
Topics: Adenoma; Cavernous Sinus; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meningeal Neoplasms; | 1988 |
Sensitivity of Gd-DTPA-enhanced MR imaging of benign extraaxial tumors.
Topics: Adenoma; Brain Neoplasms; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meningiom | 1988 |
Pituitary adenomas in patients with Cushing disease: initial experience with Gd-DTPA-enhanced MR imaging.
Topics: ACTH Syndrome, Ectopic; Adenoma; Contrast Media; Cushing Syndrome; Female; Gadolinium; Gadolinium DT | 1987 |
Contrast enhancement of spontaneous animal CNS tumors with gadolinium DTPA: a correlation of MRI with x-ray CT.
Topics: Adenoma; Animals; Astrocytoma; Brain Neoplasms; Cat Diseases; Cats; Dog Diseases; Dogs; Female; Magn | 1985 |